chrisvoncsefalvay/vaers-outcomes huggingface dataset:
felt warm; headache; Arm discomfort; body ache; A spontaneous report was received from a consumer concerning a 30 year old, female who experienced sore arm, headache, body ache, felt warm., after receiving mRNA-1273.   The medical history was not provided. Concomitant product use was not provided.  The consumer received the Moderna COVID-19 Vaccine on 4Jan2021 possible Lot Batch number 025L20A in her left arm. On Tuesday 5Jan2021 around 11AM the she started experience side effects that included sore arm, headache, body ache, felt warm. The consumers temperature she mentioned is usually 98.4 degrees. She mentioned she felt warm and her temperature registered at 98.8 degrees.   The consumer did take Tylenol as treatment. Also mentioned she tested positive for COVID-19 on 06Dec2020. The symptoms of her COVID-19 experience was that she was "sleepy" had a really bad sore throat, cough, lost sense of taste and smell for two days.  Treatment for the event included Tylenol 600mg just one dose has been taken. Consumer also taking an antibiotic for a tooth ache/ Cephalexin 500 mg. QTID.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
1.  Hernia Surgery on 4/12/22 - Suspicious lymph node sent to lab.  Diagnosis following Pet Scan was Chronic Lymphocytic Leukemia 2.  On 7/21/22 my feet were in extreme pain...visits to neurologist, podiatrist and vascular surgeon all reported peripheral neuropathy 3.  7/26/22  Ran Covid-19 test and I was positive for Covid-19.  Medical prescribed Medrol  Prior to the shot, I had no knowledge of these problems.  Do not know if the shot was responsible for items 1 and 2, but until I got the shot, I had not had Covid as far as I knew.
3 inch area of redness around site where vaccine given. It is also itchy and a little warm to the touch. It is the left upper arm.
Initial literature report received on 01 Nov 2010: This patient participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness (ILI) symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction (PCR) assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza (LCI). This patient had an antibody titer value of 453, 320, 320, and 640 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient did not had 4-fold increase in titer value and tested negative for seroconversion of B strain but tested positive for B strain PCR. Therefore this patient was considered as an LCI case of Influenza B. The outcome was not reported.
She ended up contracting the human papillomavirus (HPV) so she "got HPV."; She received the third dose much later than the second dose, approximately "6 years later"; This spontaneous report was received from a 21 year old female patient, referring herself. No information was provided regarding the patient's historical conditions, previous drug reactions, allergies, concurrent conditions or concomitant medications.      In 2010, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL); then, approximately in 2010, (reported as approximately "one month later" after getting the first dose), she received the second shot; the patient finally completed the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) series; however, she received the third dose much later than the second dose, she said approximately in 2016 (reported as "6 years later" after getting the second dose) (inappropriate schedule of product administration), all the three doses were administered for prophylaxis (dose, route of administration, lot number and expiration date were not reported).         On an unknown date, sometime afterwards, the patient ended up contracting the human papillomavirus (HPV) (papilloma viral infection).      The outcome of papilloma viral infection and was unknown. The causality assessment between quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) and the event was not reported.
Patient ID:   Admit Date:  8/12/2022   Discharge Date:   8/14/2022   Discharge Diagnosis:  Principal Problem:   Hyponatremia Active Problems:   COVID-19 virus infection   Pulmonary emphysema   HTN (hypertension)     Hospital Course:  78 year old vaccinated female was admitted for hyponatremia and Covid-19 infection. She received 3 doses of Remdesivir during the hospital stay. Hyzaar was switched to Cozaar. Na has improve to 134 from 120. She is discharged home today in stable condition. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.   Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 98.2 °F (36.8 °C) Heart Rate (Monitor): 78 Pulse: 84 BP: 110/61 Respirations: 18 SpO2: 96 % O2 Flow Rate (l/min): 2 l/min General Appearance: no distress  Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally  Heart: regular rate and rhythm Abdomen: soft, non-tender  Skin: No rashes or lesions  Extremities: full ROM Neuro: alert, normal strength and tone    Consults:  IP CONSULT TO NEPHROLOGY IP CONSULT TO SOCIAL WORK   Significant Diagnostic Studies:   CXR   Operations: none   Disposition:  Home    Discharge Condition:  Fair
Her chin, cheek, lips, it sort of feels numb, like it's dead; Her chin, cheek, lips, it sort of feels numb, like it's dead; Shingles; COVID-19 virus; COVID-19 virus; tingling in the face, hand, torso and feet; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 (Lot number: ER8731) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 22Jan2022, outcome "unknown" and all described as "COVID-19 virus"; HERPES ZOSTER (non-serious) with onset 03Feb2022, outcome "recovered", described as "Shingles"; PARAESTHESIA (non-serious) with onset May2021, outcome "unknown", described as "tingling in the face, hand, torso and feet"; HYPOAESTHESIA (non-serious), HYPOAESTHESIA ORAL (non-serious), outcome "unknown" and all described as "Her chin, cheek, lips, it sort of feels numb, like it's dead". Clinical course was reported as follows. She's had tingling in the face, hand, torso and feet. She took the shot on her left arm, hanging out the window at the drive through and within less than 3 weeks she had tingling in her head, face, on her left side, all on her left side, same side she was injected on 30Apr2021. She has had this problem ever since May2021, tingling face, scalp, hand, feet, torso, but her leg, even run down her leg to her knee. Only on the left side. She never had it before getting the COVID-19 shot. She is home alone, her husband passed away 3-year-ago. This really worries her, she has never been sick, but since this time, she has had COVID-19 virus, she went and had the test on 22Jan2022, results were positive. On 03Feb2022, she got shingles and just got over them and the tingling is back. And the tingling back on the left side of her face. Her chin, cheek, lips, it sort of feels numb, like it's dead. She went to NP and MD 5 times, back and forth, they had not a clue and of course it's all over the internet that it could be Guillain-Barre Syndrome or it could be MS. It says it is a symptom from covid 19 vaccine. The article says it's Pfizer covid 19 vaccine. It's on withheld, it's not just Pfizer vaccine, but that is the one that she took. It will be a year in May.  The articles, say they have gone to neurologists and they say it is from the vaccine. All summer long she was paranoid. Reports say it can give shingles.
Severe Fever, Chest pain, Body pains, Spinal cord pain I was unable to walk properly for 2 days
Numerous erythematous hives with edema on trunk and upper extremities.   Treatment- Epinephrine-SQ, Benedryl, Prednisone, Atarax
Irritable Bowel Syndrome flare-up;  Abdominal pain, more gas than usual, bloating.  Lasted about 5 weeks, tapering off starting about week 5 & 6.. This is unusual, there were none of the usual triggers for me (no extra stress, no unusual dietary items, etc.).
3 minutes after getting vaccine while drawing blood from a fingerstick patient started feeling dizzy, a few minutes later she became pale but still coherent and conscious. Water was given and she was able to drink while sitting up, she was later laid down and given a lollipop and ice pack was placed under her neck, BP was 100/70 @ 4:20 pm, her color return and Dr. was informed and saw the patient. RN recheck BP 112/66  @ 4:43 pm - Mom and patient both said that patient was fine and Dr. was informed and patient was released. Patient waited 25 minutes after vaccine and cbc (fingerstick).
chills cough body aches extreme tiredness (the same symptoms I had when I contracted the Coronavirus 11 weeks ago)
1600 patient c/o left hand tingling. left sided neck numbness 1610 patient c/o lips tingling 1610 Benadryl 25mg PO given 1640 Discharged to home with symptoms resolved. Informed to notify PCP. Verbalized understanding.
This case was reported by a consumer via call center representative and described the occurrence of hypersensitivity reaction in a adult female patient who received Herpes zoster (shingrix) for prophylaxis.  Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE) for prophylaxis. On an unknown date, the patient received the 1st dose of shingrix and PNEUMONIA VACCINE. On an unknown date, 1 day after receiving shingrix, the patient experienced hypersensitivity reaction, lip pruritus, red face, skin blotches, ear pruritus and ear swelling. The patient was treated with ambiguous medication nos (Epipen (Nos)). On an unknown date, the outcome of the hypersensitivity reaction, lip pruritus, red face, skin blotches, ear pruritus and ear swelling were recovered/resolved.  It was unknown if the reporter considered the hypersensitivity reaction, lip pruritus, red face, skin blotches, ear pruritus and ear swelling to be related to shingrix. Additional details were provided as follows: The patient self-reported this case. The age at vaccination was unknown. In 2019, the patient received first dose of shingrix and on the same day patient received Pneumonia vaccine. The patient stated the next morning after receiving the shingrix and Pneumonia vaccine, she began experiencing symptoms that included itching of both lips, redness of the face, blotchy patches on the face, and itching and swelling of both ears. The patient reached out to the healthcare professional (HCP) that administered the vaccine and was advised to come into the office immediately. At the office the patient was administered EpiPen and waited in the office for approximately 1 hour, for observation. 1 day after vaccinations, the healthcare professional stated that the patient had experienced a hypersensitivity reaction to the vaccine and was advised to not proceed with the second dose. The reporter considered the lip pruritus, red face, blotchy, ear pruritus, ear swelling and hypersensitivity to be related to Pneumonia vaccine. The reporter consented to follow up.
had shingles, had shot before them, second vaccine after; painful; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles and pain were recovered/resolved.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 18-JUN-2022 Reporter's comments: This case was reported by consumer via interactive digital media. The case was reported by the consumer for himself/herself. The patient stated that he/she had shingles and it was so horrible and painful. The patient had the shot before he/she had them. The reporter hoped and pray to never get them again. The reporter also had the second vaccine after. Additional supportive information:  Follow-up would not possible, as no contact details were available. This case also has been linked with case US2022AMR095627, reported by the same reporter.
Pt  is currently breastfeeding. Pt reported having 4 clogged milk ducts. 3 on the same side as injection and one on the other. All have resolved at this time through breastfeeding and pumping. No other symptoms.
Rotateq administered and 4/6/07 will rest of 2mo immun. The next evening had episode of vomiting/diarrhea which worsened over the following 3 days >12 Diarrhea stools/day. She became dehydrated and was admitted to hospital for 3 days for treatment of rotavirus gastroenteritis. Multiple family members came down with milder versions.  5/1/07 Received medical records from hospital which reveals patient experienced vomiting & diarrhea x 5 days & was dehydrated on presenting to ER.  Seen by PCP on 4/9 & sent home.  Continued to have diarrhea.  Returned to PCP who admitted to hospital 4/12-4/15/07 for significant dehydration.  Temp 101.2 in ER & had lost 1# over last week.  Received IVF w/good response. FINAL DX: Rotavirus gastroenteritis, resolved; and dehydration, resolved.
Patient stated that she experienced sharp shoulder pain immediately after the vaccine on 04/20/21. She went to the Emergency room on 04/21/21 at 1130am. Her ER discharge notes state that she has SIRVA, injection site reaction due to vaccination technique.
Tinnitus and dizziness started 3 days after receiving the second dose; Tinnitus and dizziness started 3 days after receiving the second dose; This is a spontaneous report from a contactable other hcp (patient). A 37-years-old non-pregnant female patient received bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 17:00 (age at vaccination 37years), as DOSE 2, SINGLE for covid-19 immunisation at facility. Medical history included depression, anxiety from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine, solution for injection), dose 1, administered in Arm Left on 14Jan2021 04:45 (Batch/Lot number: EJ1685) for covid-19 immunisation. On 27Feb2021, the patient experienced tinnitus and dizziness started 3 days after receiving the second dose. The events resulted in physician office visit. Therapeutic measures were taken as a result of events with meclizine. Device Date was 03Jun2021. The clinical outcome of the events was Recovered with Sequel in 2021.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
c/o feeling ill when pt arrived home p/school;next day felt ill @ school;t102 orally;pt exp strange taste in mouth & having visual hallucinations;pt seen by MD who felt pt had a virus;
p/vax pt exp pain in rt hip joint;no tx given;addtl info recv states pt condition is worsening;
This is a spontaneous report from a contactable nurse. The nurse reported that a 23-months-old, female patient received the fourth dose of PREVNAR 13 (Lot n. F45130, expiration date 01Feb2014) at 0.5 ml single, intramuscularly, on 09Jul2012 for immunization. The relevant medical history included allergy to egg and milk since an unknown date. There were no relevant drug history, drug allergies and family history. The relevant concomitant medications were unknown. Previously the patient received the first dose of PREVNAR 13 (Lot n. E87534), at 0.5 ml single, at the age of 2 months, intramuscularly in the left thigh on 05Oct2010 for immunization; the second dose of PREVNAR 13 (Lot n. E88939) at 0.5 ml single, at the age of 5 months, intramuscularly in the left thigh on 03Jan2011 for immunization and the third dose of PREVNAR 13 (Lot n. E89951) at 0.5 ml single, at the age of 7 months, intramuscularly in the left thigh on 25Feb2011 for immunization. The patient had swelling and hives at the injection site on 10Jul2012. The nurse elaborated that the patient had redness at the site of injection so they made a circle at the site of injection and the redness spread beyond the circle within 12 hours. The relevant laboratory data was unknown. The events resulted in a doctor visit. Therapeutic measures taken for the reported events included BENADRYL and ibuprofen for 72 hrs. The patient recovered from the events on 16Jul2012. Follow-up (30Jul2012): New information reported from the same contactable nurse includes: PREVNAR 13 treatment details, adverse event information updated, therapeutic measures, medical history, outcome of the events, previous vaccinations information. Follow-up (31AUG2012): Follow-up attempts completed. No further information expected.
About 1:00 on Sat, 11/6/10 I started feeling nauseous, at 4:00 I vomited and also had diarrhea. This continued for 12 hours, about every 2 hours. Could not keep any fluids down until 12:00 Sunday 11/7/10. Had a low grade fever of 100.
Colostomy takedown, lysis of intra-abdominal adhesions. The patient was admitted to the surgical ward.  Her NG tube was removed on postop day 2.  The open wound at the ostomy site was healing accordingly.  Midline incision was healing accordingly.  Diet was slowly advanced.  She had a soft formed bowel movement on postop day 6 with no blood.  Tolerating a regular diet.  Labs as below.  Discharged home. Hospital admission within 6 weeks of receiving the COVID vaccine.
Information has been received from a female who on 27-MAY-2008 was vaccinated with a single dose of ZOSTAVAX (Oka/Merck). On 30-MAY-2008 the patient experienced a square shaped red mark approximately the size of a quarter appeared at the injection site and itching as a result of this mark. At the time of the report, the patient's red mark was still present. No further information is available.
Patient reports of dizziness and light headedness. Patient was pale, diaphoretic, and hot to the touch.  Patients denies rash, trouble breathing, swelling to lips, tongue or throat or itchiness.  Unable to take a blood pressure reading due to store's emergency bag not having an appropriate size cuff or stethoscope.  Patient's father reports patient had not eaten  since noon. Patient reports he had very little  water that day. Outer jacket removed, legs elevated, cool wet cloth applied, water provided and chocolate peanut candies. ten minutes post interventions, patient reports" I am feeling a lot better" and " I am not dizzy anymore". Color returned to patients face, diaphoresis resolved, skin temperature decreased.  Father denied offer to call EMS. Encouraged Father to seek additional medical assistance.  Father and patient walked out of store thankful for nursing interventions.
Patient received RSV (Abrysvo) vaccine on 9/2/23 at Pharmacy.   Next day after receiving the vaccine, patient called to report of potential Atrial Fibrillation the patient experienced based on the A fib sensor device reader the patient wears.  Pharmacist advised patient should follow up with his doctor or go to the emergency room.  Patients doctor advised patient to go to the emergency room, where the A Fib event the patient experienced was confirmed.  Patient was treated at the emergency room and sent home.  Patient is still concerned if he will have a repeat of the A Fib event.  Pharmacy is reporting this event.
Raised redness area with ring around area where shot given, pain down to elbow, hives on face, and chest tightness. Patient was advised to go to the ER and follow up with primary care physician and take Benadryl.
received COVID19 vaccine with no label on syringe. Order was placed for Pfizer vaccine but bag had Moderna label applied to bag only. Pharmacist notified. New dose to be sent for patient administration with correct labeling.
Clenched jaw for several months, resulting in tension headaches. Began to wane after 6 weeks and fully resolved after 12 weeks.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reaction or allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 injection, lot # M027552, expiration date 04-FEB-2018 (route and site of administration were not reported). During the injection, the pharmacist noticed that the syringe was leaking (exact dose administered was considered unknown). Then, he administered "another full dose" (0.5 ml) of PNEUMOVAX 23 to the patient (route and site of administration, lot # and expiration date were not reported). The reporter confirmed that the patient received more than the recommended dose of vaccine (also reported as "single 0.5 ml dose). No adverse effects were reported. Product quality complaint was involved. Additional information has been requested.
fever,  chills, generalized body aches, occurred same night as vaccine, took Tylenol, symptoms progressed, went to ED given IV antibiotics and discharged home with oral antibiotics
3SEP93 mom called reporting t100.2; c/o stomach cramps in AM denies severe HA; seen by MD;
Information has been received from a nurse concerning her 16 year old daughter who on 01-AUG-2008 was vaccinated with the second dose of GARDASIL. Concomitant therapy included an unspecified birth control medication. On approximately 01-AUG-2008 the patient experienced nausea and bone pain for about 2 weeks. The nurse noted that the only new factor between the first dose and the second dose was an initiation of an unspecified birth control medication. The patient recovered without any intervention. Additional information has been requested.
rt shoulder induration, pain, erythema that began 24hrs p/DTP @ site of inj;it is resolving;
7 cm erythematous, hot, painful streak from injection site ant thigh -> behind L knee -> just below L knee. Febrile Rx Amox 125/5 TID X 7d.  Motrin\Tylenol
Event Symptoms : Headache; Dizzy; Aches; Chills; Nauseous; Flushed face; Hot flash; Sneezing; Fatigue; Sore arm; No energy;  Extremely pale;  Treatment: Rest; Tylenol; Green Tea Frappuccino; Chicken Noodle Soup; Crackers;
Got the booster in left arm, not sure if its in the muscle but my arm is HOT, you can feel the warmth through clothes and its red. The heat is bothering me...I iced it when I got home, tuesday and wednesday and took motrin.